These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35401832)

  • 1. Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy.
    Jiang W; Chen L; Guo X; Cheng C; Luo Y; Wang J; Wang J; Liu Y; Cao Y; Li P; Wang Z; Ran H; Zhou Z; Ren J
    Theranostics; 2022; 12(6):2987-3006. PubMed ID: 35401832
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells.
    Gopisetty MK; Kovács D; Igaz N; Rónavári A; Bélteky P; Rázga Z; Venglovecz V; Csoboz B; Boros IM; Kónya Z; Kiricsi M
    J Nanobiotechnology; 2019 Jan; 17(1):9. PubMed ID: 30670028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional PLGA Nanobubbles as Theranostic Agents: Combining Doxorubicin and P-gp siRNA Co-Delivery Into Human Breast Cancer Cells and Ultrasound Cellular Imaging.
    Yang H; Deng L; Li T; Shen X; Yan J; Zuo L; Wu C; Liu Y
    J Biomed Nanotechnol; 2015 Dec; 11(12):2124-36. PubMed ID: 26510307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
    J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies.
    Li B; Xu H; Li Z; Yao M; Xie M; Shen H; Shen S; Wang X; Jin Y
    Int J Nanomedicine; 2012; 7():187-97. PubMed ID: 22275834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ascorbate promotes the cellular accumulation of doxorubicin and reverses the multidrug resistance in breast cancer cells by inducing ROS-dependent ATP depletion.
    Liu Y; Zhang L; Ma Z; Tian L; Liu Y; Liu Y; Chen Q; Li Y; Ma E
    Free Radic Res; 2019 Jul; 53(7):758-767. PubMed ID: 31170853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Sequentially Responsive Nanosystem Breaches Cascaded Bio-barriers and Suppresses P-Glycoprotein Function for Reversing Cancer Drug Resistance.
    Liu J; Zhao L; Shi L; Yuan Y; Fu D; Ye Z; Li Q; Deng Y; Liu X; Lv Q; Cheng Y; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54343-54355. PubMed ID: 32959645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of a Core-Shell Nanoplatform to Overcome Multidrug Resistance via ATP Deprivation.
    Liu G; Wang L; Liu J; Lu L; Mo D; Li K; Yang X; Zeng R; Zhang J; Liu P; Cai K
    Adv Healthc Mater; 2020 Oct; 9(20):e2000432. PubMed ID: 32945146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH and redox dual-responsive nanoparticles based on disulfide-containing poly(β-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer.
    Zhang S; Guo N; Wan G; Zhang T; Li C; Wang Y; Wang Y; Liu Y
    J Nanobiotechnology; 2019 Oct; 17(1):109. PubMed ID: 31623608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
    J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversion of Multidrug Resistance by Co-Encapsulation of Doxorubicin and Metformin in Poly(lactide-co-glycolide)-d-α-tocopheryl Polyethylene Glycol 1000 Succinate Nanoparticles.
    Shafiei-Irannejad V; Samadi N; Salehi R; Yousefi B; Rahimi M; Akbarzadeh A; Zarghami N
    Pharm Res; 2018 Apr; 35(6):119. PubMed ID: 29671072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.
    Shafiei-Irannejad V; Samadi N; Yousefi B; Salehi R; Velaei K; Zarghami N
    Chem Biol Drug Des; 2018 Jan; 91(1):269-276. PubMed ID: 28782285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system.
    Wang X; Teng Z; Wang H; Wang C; Liu Y; Tang Y; Wu J; Sun J; Wang H; Wang J; Lu G
    Int J Clin Exp Pathol; 2014; 7(4):1337-47. PubMed ID: 24817930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctionalized Micelles Facilitate Intracellular Doxorubicin Delivery for Reversing Multidrug Resistance of Breast Cancer.
    Cao A; Ma P; Yang T; Lan Y; Yu S; Liu L; Sun Y; Liu Y
    Mol Pharm; 2019 Jun; 16(6):2502-2510. PubMed ID: 30998372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.